Pfizer plans another $500M in cost cuts, expects $3.1B in revenue from Seagen in 2024news2023-12-13T12:37:41+00:00December 13th, 2023|Endpoints News|
Vertex unveils PhIII plans for non-opioid drug following mid-stage success in peripheral neuropathic painnews2023-12-13T12:17:43+00:00December 13th, 2023|Endpoints News|
Exclusive: Parker Institute expands to Weill Cornell Medicine as it grows immunotherapy worknews2023-12-13T12:00:42+00:00December 13th, 2023|Endpoints News|
Immunotherapy biotech EvolveImmune raises $37M from backers like Pfizer, Takeda and BMSnews2023-12-13T12:00:15+00:00December 13th, 2023|Endpoints News|
UMass medical school’s manufacturing business trims 36 positionsnews2023-12-13T10:35:39+00:00December 13th, 2023|Endpoints News|
House passes sweeping healthcare price transparency reforms, reining in PBM practicesnews2023-12-12T19:52:33+00:00December 12th, 2023|Endpoints News|
Novo Nordisk calls IRA ‘unprecedented departure’ from US Constitutionnews2023-12-12T19:31:39+00:00December 12th, 2023|Endpoints News|
Dizal presents updated PhII PTLC data, plans to file for accelerated approval in the US next yearnews2023-12-12T19:19:10+00:00December 12th, 2023|Endpoints News|
FDA establishes new advisory committee for genetic metabolic disease treatmentsnews2023-12-12T19:14:58+00:00December 12th, 2023|Endpoints News|
Over 200 critical medicines to be monitored for shortages in the EU news2023-12-12T18:44:31+00:00December 12th, 2023|Endpoints News|
